The bottom-up approach to bounding potential low-dose cancer risks from formaldehyde: An update
- PMID: 26851508
- DOI: 10.1016/j.yrtph.2016.01.021
The bottom-up approach to bounding potential low-dose cancer risks from formaldehyde: An update
Abstract
In 2013, we proposed a novel bottom-up approach to bounding low-dose cancer risks that may result from small exogenous exposures to chemicals that are always present in the body as a result of normal biological processes. The approach utilizes the background cancer risk and the background (endogenous) concentration of a cancer-related exposure biomarker in specific target tissues. After allowing for statistical uncertainty in these two parameters, the ratio of the background risk to background exposure provides a conservative slope factor estimate that can be utilized to bound the added risk that may be associated with incremental exogenous exposures. Our original bottom-up estimates were markedly smaller than those obtained previously by the US Environmental Protection Agency (USEPA) with a conventional top-down approach to modeling nasopharyngeal cancer and leukemia mortality data from a US worker cohort. Herein we provide updated bottom-up estimates of risk for these two cancers that are smaller still, and rely upon more robust estimates of endogenous and exogenous formaldehyde-DNA adducts in monkeys and a more robust estimate of the DNA adduct elimination half-life in rats, both obtained very recently. We also re-examine the worker mortality data used by USEPA in developing its estimate of human leukemia incidence from lifetime exposure to 1 ppm airborne formaldehyde. Finally, we compare a new bottom-up slope estimate of the risk of rat nasal cancer with conventional top-down estimates obtained with empirical dose-response modeling of rat nasal cancer bioassay data.
Keywords: Bottom-up approach; Carcinogenic risk assessment; Endogenous formaldehyde; Exogenous formaldehyde; Formaldehyde-DNA adducts; Upper 95% confidence bound.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.Risk Anal. 2003 Jun;23(3):473-87. doi: 10.1111/1539-6924.00328. Risk Anal. 2003. PMID: 12836840
-
Effects of endogenous formaldehyde in nasal tissues on inhaled formaldehyde dosimetry predictions in the rat, monkey, and human nasal passages.Toxicol Sci. 2014 Apr;138(2):412-24. doi: 10.1093/toxsci/kft333. Epub 2014 Jan 2. Toxicol Sci. 2014. PMID: 24385418
-
Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia.Toxicol Sci. 2010 Aug;116(2):441-51. doi: 10.1093/toxsci/kfq061. Epub 2010 Feb 22. Toxicol Sci. 2010. PMID: 20176625 Free PMC article.
-
Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.Crit Rev Toxicol. 2006 Nov-Dec;36(10):821-35. doi: 10.1080/10408440600977669. Crit Rev Toxicol. 2006. PMID: 17118731 Review.
-
[Assessment of carcinogenicity of formaldehyde based on the newest literature data].Med Pr. 2007;58(6):527-39. Med Pr. 2007. PMID: 18421935 Review. Polish.
Cited by
-
Mode of action-based risk assessment of genotoxic carcinogens.Arch Toxicol. 2020 Jun;94(6):1787-1877. doi: 10.1007/s00204-020-02733-2. Epub 2020 Jun 15. Arch Toxicol. 2020. PMID: 32542409 Free PMC article. Review.
-
Re-evaluation of the WHO (2010) formaldehyde indoor air quality guideline for cancer risk assessment.Arch Toxicol. 2017 Jan;91(1):35-61. doi: 10.1007/s00204-016-1733-8. Epub 2016 May 21. Arch Toxicol. 2017. PMID: 27209488 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical